Drug Safety data, analytics, and insights
Advera Health’s Evidex data aggregation platform is a scalable, flexible, and agile way to access and analyze drug safety data
Advera Health’s Evidex data aggregation platform is a scalable, flexible, and agile way to access and analyze drug safety data
Cloud based drug safety data aggregation platform provides powerful insights using both Advera Health curated data and structured internal and alternative safety data sources. Powered by the proprietary RxFilter® data optimization technology, Evidex supports a broad array of safety signal detection and risk mitigation use cases.
Learn more
Clean, standardized data architecture and RxFilter® data optimization technology allow for simple and efficient intake of third party data sources into Evidex. Straight forward APIs help power leading enterprise software applications to feed Advera Health data into their applications.
Learn more
Comparative research that provides evidence reviews of new and soon-to-be launched drugs, insight into labeling changes and FDA safety communications, and evidence driven insight into other key drug issues.
Learn more
Custom advisory services to aid market access and commercialization strategies using annotated data from curated clinical trials results and structured real world data. Support new drug launches, defend market position and help pharmaceutical companies tell their evidence based story.
Learn more
Annotated data from curated clinical trial results. The most comprehensive safety focused trials database featuring data from ClinicalTrials.gov, published research, abstracts, presentations, and more.
FDA Adverse Reporting System (FAERS) and VigiBase. The industry’s new gold-standard for cleaned, de-duplicated, and dynamically linked FAERS and VigiBase data.
Social monitoring data from Booz Allen Hamilton’s Epidemico, client licensed claims or EHR data combines in Evidex for powerful signal detection and management.